The importance of MHC-I and MHC-II responses in vaccine efficacy against lethal herpes simplex virus type 1 challenge

Immunology

Volumn 91, Issue 3, 1997, Pages 430-435

  Ghiasi, H ^a   Roopenian, D C ^c   Slanina, S ^a   Cai, S ^a   Nesburn, A B ^a,b   Wechsler, S L ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN; NEUTRALIZING ANTIBODY; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HERPES SIMPLEX VIRUS 1; IMMUNE RESPONSE; INFECTION PREVENTION; INTRAPERITONEAL DRUG ADMINISTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PLAQUE FORMING CELL; PRIORITY JOURNAL; VACCINATION;

EID: 0030874198     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1997.00261.x     Document Type: Article

References (40)

1. GHIASI H., KAIWA R., NESBURN A.B., SLANINA S. & WECHSLER S.L. (1994) Expression of seven herpes simplex virus type 1 glycoproteins (gB gC, gD gE, gG, gH and gI): Comparative protection against lethal challenge in mice. J Virol 68, 2118.
2. SETHI K.K. (1983) Effects of monoclonal antibodies directed against herpes simplex virus specified glycoproteins on the generation of virus specific and H-2 restricted cytotoxic T-lymphocytes. J Gen Virol 64, 2033.
3. KAPOOR A.K., BUCKMASTFR A., NASH A.A., FIELD H.J. & WILDY P. (1982) Role of neutralizing antibodies and T cells in pathogenesis of herpes simplex virus infection in congenitally athymic mice. Immunology 5, 259.
4. NASH A.A. & CAMBOUROPOULOS P. (1993) The immune response to herpes simplex virus. Virology 4, 181.
5. DAVIS W.B., TAYLOR J.A. & OAKES J.E. (1979) Ocular infection with herpes simplex virus type 1: prevention of acute herpetic encephalitis by systemic administration of virus-specific antibody. J Infec Dis 140, 534.
6. RAIZMAN M.B. & FOSTER C.S. (1988) Passive transfer of anti-HSV-1 IgG protects against stromal keratitis in mice. Curr Eye Res 7, 823.
7. + cells. J Virol 65, 6008.
8. SCHRIER R.D., PIZER L.I. & MOOREHEAD J.W. (1983) Type specific delayed hypersensitivity and protective immunity induced by isolated herpes simplex virus glycoprotein. J Immunol 130, 1413.
9. NAGAFUCHI S., HAYASHIDA I., HIGA K., WADA T. & MORI R. (1982) Role of Lyt-1 positive immune T cells in recovery from Herpes simplex virus infection in mice. Microbiol Immunol 26, 359.
10. BONNEAU R.H. & JENNINGS S.R. (1990) Herpes simplex virus specific cytolytic T lymphocytes restricted to a normally low responder H-2 allele are portective in vivo. Virology 174, 599.
11. BONNEAU R. & JENNINGS S.R. (1989) Modulation of acute and latent herpes simplex virus infection in C57BL/6 mice by adoptive transfer of immune lymphocytes with cytolytic activity. J Virol 63, 1480.
12. SETHI K.K., OMATA Y. & SCHNEWEIS K.E. (1983) Protection of mice from fatal herpes simplex virus type 1 infection by adoptive transfer of cloned virus-specific and H-2 restricted cytotoxic T lymphocytes. J Gen Virol 64, 443.
13. GERMAIN R.N. & MARGULIES D.H. (1993) The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol 11, 403.
14. + T cells. Curr Biol 7, 367.
15. + cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I deficient mice. J Exp Med 178, 1465.
16. WECHSLER S.L., NESBURN A.B., WATSON R.J., SLANINA S.M. & GHIASI H. (1988) Fine mapping of the latency related gene of herpes simplex virus type 1: alternative splicing produces distinct latency related-RNAs containing open reading frames. J Virol 62, 4051.
17. 2-microglobulin locus in mouse embryonic stem cells by homologous recombination. Proc Natl Acad Sci USA 86, 8932.
18. COSGROVE D., GRAY D., DIERICH A. et al. (1991) Mice lacking MHC Class II molecules. Cell 66, 1051.
19. GHIASI H., NESBURN A.B. & WECHSLER S.L. (1996) Improve protection against HSV-1 infection following vaccination with a mxiture of 7 recombinant HSV glycoproteins. Vaccine 14, 107.
20. GHIASI H., KAIWAR R., NESBURN A.B. & WECHSLER S.L. (1991) Immunoselection of recombinant baculoviruses expressing high levels of biologically active herpes simplex virus type 1 glycoprotein D. Arch Virol 121, 163.
21. PERNG G.C., THOMPSON R.L., SAWTELL N.M. et al. (1995) An avirulent ICP34·5 deletion mutant of herpes simplex virus type 1 is capable of in vivo spontaneous reactivation. J. Virol 69, 3033.
22. FINCK B.K., YUNG C.M. & CARTERON N.L. (1992) The role of T cell subsets in the response to anti-CD3 monoclonal antibodies. Clin Immunol Immunopathol 65, 234.
23. + cytolytic T cells. Nature 344, 742.
24. GRUSBY M.J., JOHNSON R.S., PAPAIOANNOU V.E. & GLIMCHER L.H. (1991) Depletion of CD4 T cells in major histocompatibility complex class II deficient mice. Science 253, 1417.
25. LADEL C.H., DAUGELAT S. & KAUFMANN S.H.E. (1995) Immune response to Mycobacterium bovis bacille Calmette-Guérin infection in major histocompatibility complex class I and II deficient knock-out mice: contribution of CD4 and Cd8 T cells to acquired resistance. Eur J Immunol 25, 377.
26. MANICKAN E. & ROUSE B.T. (1995) Roles of different T-cell subsets in control of herpes simplex virus infection determined by using T-cell deficient mouse models. J Virol 69, 8178.
27. + T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. J Gen Virol 68, 825.
28. NESBURN A.B. & TROUSDALE, M.D. (1981) Treatment of acute and chronic ocular herpes infection with acyclovir. in: Herpetische Augenerkrankungen. (ed. R. Sundmacher), p. 309. J.F. Bergmann Verlag, München.
29. LARSEN H.S., FENG M., HOROHOV D.M., MOORE R.N. & ROUSE B.T. (1984) Role of T-lymphocyte subsets in recovery from herpes simplex virus infection. J Virol 50, 56.
30. MARTIN S. & ROUSE B.T. (1987) the mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: viral clearance. J Immunol 138, 3431.
31. NEWELL C.K., MARTIN S., SENDELE D., MERCADAL C.M. & ROUSE B.T. (1989) Herpes simplex virus-induced stromal keratitis: role of T-lymphocyte subsets in immunopathology. J Virol 63, 769.
32. HENDRICKS R.L. & TUMPEY T.M. (1990) Contribution of virus and immune factors to herpes simplex virus type 1 induced corneal pathology. Invest Ophthalmol Vis Sci 31 (1929)
33. HENDRICKS R.L., TUMPEY T.M. & FINNEGAN A. (1992) IFN-gamma and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice. J Immunol 149, 3023.
34. BLACKLAWS B.A., KRISHNA S., MINSON A.C. & NASH A.A. (1990) Immunogenicity of herpes simplex virus type 1 glycoproteins expressed in vaccinia virus recombinants. Virology 177, 727.
35. HILL T.J., FIELD H.J. & BLYTH W.A. (1975) Acute and recurrent infection with herpes simplex virus in mouse: a model for studying latency and recurrent disease. J Gen Virol 28, 341.
36. HILL T.J., BLYTH W.A. & HARBOUR D.A. (1983) Recurrence of herpes simplex in the mouse requires an intact nerve supply to the skin. J Gen Virol 64, 2763.
37. COOK S.D., PAVELOFF M.J., DOUCET J.J., COTTINGHAM A.J., SEDARATI F. & HILL J.M. (1991) Ocular herpes simplex virus reactivation in mice latently infected with latency associated transcript mutants. Invest Ophthalmol Vis Sci 32, 1558.
38. TULLO A.B., SHIMELD C., BLYTH W.A., HILL T.J. & EASTY D.L. (1983) Ocular infection with herpes simplex virus in nonimmune and immune mice. Arch Ophthalmol 101, 961.
39. GHIASI H. CAI S., SLANINA S., NESBURN A.B. & WECHSLER S.L. (1995) Vaccination of mice with herpes simplex virus type 1 glycoprotein D DNA produces low levels of protection against lethal HSV-1 challenge. Antiviral Res 28, 147.
40. SPRIGGS M.K., KOLLER B.H., SATO T. et al. (1992) Beta2-microglobulin-, CD8= T-cell deficient mice survive inoculation with high doses of vaccinia virus and exhibit altered IgG responses. Proc Natl Acad Sci USA 89, 6070.